ve303 high

Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting | Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, today…

8 months ago

This website uses cookies.